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Protocol
AbstrACt
Introduction Acute psychological stress, as well 
as unusual experiences including hallucinations and 
delusions, are common in critical care unit patients and 
have been linked to post-critical care psychological 
morbidity such as post-traumatic stress disorder (PTSD), 
depression and anxiety. Little high-quality research has 
been conducted to evaluate psychological interventions 
that could alleviate longer-term psychological morbidity in 
the critical care unit setting. Our research team developed 
and piloted a nurse-led psychological intervention, aimed 
at reducing patient-reported PTSD symptom severity and 
other adverse psychological outcomes at 6 months, for 
evaluation in the POPPI trial.
Methods and analysis This is a multicentre, parallel 
group, cluster-randomised clinical trial with a staggered 
roll-out of the intervention. The trial is being carried out 
at 24 (12 intervention, 12 control) NHS adult, general, 
critical care units in the UK and is evaluating the clinical 
effectiveness and cost-effectiveness of a nurse-led 
preventative psychological intervention in reducing 
patient-reported PTSD symptom severity and other 
psychological morbidity at 6 months. All sites deliver usual 
care for 5 months (baseline period). Intervention group 
sites are then trained to carry out the POPPI intervention, 
and transition to delivering the intervention for the rest 
of the recruitment period. Control group sites deliver 
usual care for the duration of the recruitment period. 
The trial also includes a process evaluation conducted 
independently of the trial team.
Ethics and dissemination This protocol was reviewed 
and approved by the National Research Ethics Service 
South Central - Oxford B Research Ethics Committee 
(reference: 15/SC/0287). The first patient was recruited in 
September 2015 and results will be disseminated in 2018. 
The results will be presented at national and international 
conferences and published in peer reviewed medical 
journals.
trial registration number ISRCTN53448131; Pre-results.
IntroduCtIon  
More than 170 000 patients are admitted 
to adult, general, critical care units in the 
National Health Service (NHS) each year.1 
It has been estimated that approximately 
50% of critically ill patients suffer serious 
emotional distress, and up to two-thirds 
have unusual experiences such as halluci-
nations and delusions, while in the unit.2 3 
Emotional distress, including severe symp-
toms of anxiety, low mood and panic, may 
be caused by a range of stressful experi-
ences that are common in the critical care 
unit: fear of dying; invasive treatments 
such as mechanical ventilation; pain and 
discomfort; inability to communicate; and 
terrifying hallucinatory delusions.2 4–6 The 
hallucinations and delusions of critical care 
strengths and limitations of this study
 ► POPPI is the first, large, multicentre cluster-
randomised clinical trial evaluating a complex 
intervention commencing in the critical care unit 
and aimed at reducing longer-term psychological 
morbidity for critical care survivors in the UK.
 ► POPPI has strong patient and public involvement, 
with former critical care patients involved in 
the development of the research question and 
intervention, training of key trial staff and as 
members of oversight committees.
 ► The trial has an embedded economic evaluation and 
an independent process evaluation.
 ► The primary outcome is patient-reported and it is 
anticipated that there may be 20%–25% missing 
data.
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unit patients have been linked to delirium, the provi-
sion and withdrawal of sedative and other psychoactive 
drugs, effects of illness (such as sepsis), immobility, 
and sensory and sleep deprivation.3 5 7 Critical care unit 
hallucinations frequently have horrifying themes such 
as conspiracy to kill by staff, torture, poisoning, demons, 
extortion or organ theft;8 thus a vicious cycle of stress, 
confusion and terror is common for critical care unit 
patients.
Experiencing acute psychological stress in the crit-
ical care unit, or having frequent memories of hallu-
cinations and delusions, are among the identified risk 
factors for longer-term post-critical care post-traumatic 
stress disorder (PTSD), depression, anxiety or cognitive 
impairment.5 9–13 Systematic reviews of survivors of crit-
ical care identified high rates of PTSD (median 20%)4 14 
and depression (median 30%),15 16 months or years after 
leaving critical care. Patients who develop serious long-
term psychological distress are at much higher risk of 
further physical morbidities and mortality,17–19 repre-
senting a serious burden to patients, to their carers and 
to NHS.20 21
Little high-quality research has been conducted to 
evaluate psychological interventions that could alleviate 
the emotional distress experienced by patients in critical 
care, with a view to preventing longer-term psycholog-
ical morbidity.22 The introduction of valid psychological 
assessment tools for use with critical care patients (eg, the 
intensive care psychological assessment tool (IPAT))23 
has made evaluation of psychological interventions more 
feasible. Research informing the best timing to provide 
psychological interventions suggests that postdischarge 
(eg, at 6 weeks24 or at outpatient follow-up clinics21) may 
be too late, and earlier intervention could be more bene-
ficial.25 In today’s NHS, practitioner psychologists are still 
a scarce resource, and a more pragmatic approach would 
be to standardise brief evidence-based psychological 
interventions to be carried out by existing critical care 
staff, who would be given the necessary training.
Our research team developed and piloted a nurse-led 
psychological intervention for critical care unit patients 
which commences within the unit and is based on up-to-
date evidence concerning psychological techniques that 
are effective in: (A) reducing acute emotional distress, (B) 
reducing the impact of unusual experiences such as hallu-
cinations and delusions and (C) preventing PTSD after a 
trauma. These are all psychological problems commonly 
associated with admission to critical care. We hypothe-
sised that these existing evidence-based psychological 
interventions could be modified to reduce the stress and 
trauma experienced by critical care unit patients, and be 
delivered by specially trained, well-motivated critical care 
nurses. There is an urgent need to evaluate their effec-
tiveness in the critical care unit setting.
This protocol was informed by the Psychological 
Outcomes following a nurse-led Preventative Psycholog-
ical Intervention for critically ill patients (POPPI) feasi-
bility study (ISRCTN61088114) which looked at feasibility 
and acceptability of both the intervention and the trial 
procedures.
MEthods
Aim and objectives
The POPPI trial aims to evaluate the clinical effec-
tiveness and cost-effectiveness of a complex nurse-led 
preventative psychological intervention in reducing 
patient-reported PTSD symptom severity, and other 
reported psychological problems, at 6 months. The 
specific objectives are:
 ► to evaluate the effect of the complex intervention on 
patient-reported PTSD symptom severity and other 
psychological outcomes and quality of life at 6 months; 
and
 ► to estimate, in an integrated economic analysis, the 
cost-effectiveness of the intervention.
In addition, an integrated process evaluation will be 
conducted to assess the fidelity, dose and reach of the 
implementation of the intervention, and to identify 
important contextual factors to better understand how 
the intervention may work.
study design and setting
The POPPI trial is a multicentre, parallel group, clus-
ter-randomised clinical trial (cluster-RCT), conducted in 
24 NHS adult, general, critical care units.
Intervention
The POPPI trial will evaluate a intervention comprising 
three elements:
1. Creating a therapeutic environment in critical care
2. Three stress support sessions for patients screened as 
acutely stressed
3. Relaxation and recovery programme for patients 
screened as acutely stressed
An education package (two training courses and associ-
ated materials) to train critical care staff to carry out the 
three elements has been developed and piloted by our 
research team and will be described in detail elsewhere 
(paper under review for publication).
sites
NHS adult, general, critical care units (‘sites’) are eligible 
to participate if they are able to commit to the following 
criteria:
 ► show that recruitment, data collection and delivery of 
the intervention are feasible;
 ► adherence to cluster-randomisation;
 ► Identify two joint-Principal Investigators (PIs) (a 
nurse and a doctor) to lead the trial locally;
 ► agree, where possible, to recruit all eligible patients 
and to maintain a screening and enrolment log; and
 ► continue active participation in the Case Mix 
Programme (CMP)—the national clinical audit for 
adult critical care in England, Wales and Northern 
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Ireland coordinated by the Intensive Care National 
Audit & Research Centre (ICNARC).
Sites who piloted the intervention during the POPPI 
feasibility study are not eligible to participate in the trial.
Randomisation
The 24 sites will be randomly assigned to either the 
intervention group (n=12) or the control group (n=12), 
by the ICNARC CTU, using a restricted randomisation 
approach to ensure balance across the groups in terms of 
geographical location, hospital teaching status and size of 
unit. For each group of eight sites, the individual sites will 
be randomised (4:4) in their second month of recruit-
ment. It is necessary to randomise on a cluster (‘site’), 
rather than individual level to avoid contamination of 
usual care, as it would not be possible to restrict parts of 
the intervention to individual patients.
Sites randomised to the intervention group are respon-
sible for selecting three POPPI nurses based on a person 
specification which includes:
 ► Registered nurse with ≥3 years critical care clinical 
experience
 ► Effective communicator, with patients and their fami-
lies, colleagues and collaborators
 ► Able to work flexibly
 ► Interested in improving psychological care of patients
 ► Organised and able to manage a busy schedule
Timeline
The 24 sites will open to recruitment in three groups of 
eight sites at 2-month intervals and recruit patients over 
a 17-month period (see figure 1). Control group sites 
will deliver usual care for the duration of the recruit-
ment period. Intervention group sites will deliver usual 
care from months 1 to 5. Usual care is defined as patients 
receiving psychological support or treatment at the 
discretion of the treating clinician(s) following standard 
practice at their site.
After month 5, intervention group sites will undergo a 
1-month transition period, during which they will tran-
sition from delivering usual care to delivering the inter-
vention (see figure 2). At the beginning of the transition 
period, all POPPI nurses at a site will attend a 3-day 
POPPI nurse training course. Following the training 
course and completion of a local intervention site initia-
tion visit, the POPPI nurses and local education/research 
teams will commence delivery of the POPPI intervention. 
During the transition period, each POPPI nurse should 
deliver stress support sessions to at least one recruited 
patient, identified (using the IPAT) as being stressed and 
at high risk of psychological morbidity. In parallel, the 
POPPI nurses and local education/research teams will 
encourage culture change in their unit to create a thera-
peutic environment. This will be done by ensuring all clin-
ical critical care staff complete the POPPI online training 
and through other educational activities (eg, seminars 
and short presentations, bedside teaching and display 
of materials reinforcing key messages from the POPPI 
online training). At the end of this transition period, the 
POPPI nurses will undergo a skills development assess-
ment. Following the transition period, the intervention 
will be delivered until the end of the recruitment period.
POPPI nurse training course
The POPPI nurse training course is a 3-day central course 
to train POPPI nurses in their new role. The focus of the 
course is on learning and practising the skills required 
to deliver the stress support sessions with patients. The 
course was designed by the trial team in consultation with 
experts in medical education and cognitive behavioural 
therapy training, and is delivered by a psychologist, two 
senior nurses and a research assistant.
The course will cover:
 ► Understanding critical care patients’ stress (including 
patient representative talks and videos)
 ► Learning the skills needed to deliver stress support 
sessions
 ► Content of each of the stress support sessions
 ► Observing (in person and expert videos) example 
stress support sessions
 ► Practising each of the stress support sessions
 ► Using the patient booklet to create personal action 
plans
Figure 1 POPPI cluster-randomised clinical trial schedule.
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 ► Debriefing and support arrangements
Associated materials include: a precourse theory 
booklet, a training folder and POPPI nurse training 
manual on the three stress support sessions; a tablet 
computer with a ‘relax and recover’ app for patients to 
use with help from nurses and family; and a self-help 
booklet and digital video disc (DVD) for patients to take 
home.
The POPPI nurse role also includes; encouraging clin-
ical staff in their units to complete the POPPI online 
training; promoting the screening of patients with IPAT; 
and teaching good communication skills and psycholog-
ical care (reinforcing key messages from the POPPI online 
training) at the bedside. These tasks will be completed in 
conjunction with the research/education teams at each 
intervention site as a team approach and training will be 
provided by the trial team at intervention site initiation 
visits held locally.
Debriefing and support for POPPI nurses
All POPPI nurses will be allocated a trainer from the 
POPPI training team to provide debriefing and support 
following the training course. Debriefing and support will 
focus on enhancing nurses’ skills and discussing patients’ 
cases. The first debriefing and support session will be 
carried out once a POPPI nurse has delivered stress 
support sessions to their first patient. Once all POPPI 
nurses at the site have delivered stress support sessions 
to at least one patient each, the POPPI training team 
will visit the POPPI nurses in their units to offer further 
support. During the visit, POPPI nurses will also undergo 
a skills development assessment, to ensure they meet the 
required standards for delivering the sessions. If neces-
sary, further support and training will be offered prior 
to the delivery of further sessions with patients. POPPI 
nurses will continue to receive debriefing and support 
either via telephone call or site visit.
Figure 2 Site timeline during transition period. IPAT, intensive care psychological assessment tool.
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Creating a therapeutic environment
Each intervention group site will create a therapeutic 
environment by encouraging culture change in their 
unit. This will be facilitated by ensuring all clinical crit-
ical care unit staff complete the POPPI online training 
and by teaching and modelling good communication 
skills and psychological care at the bedside. The POPPI 
online training is an online training course designed to 
aid the creation of a calm, less stressful environment by 
reducing stressors in the environment and using good 
communication with patients. The POPPI online training 
takes approximately 30 min to complete and comprises 
five sections (understanding the stresses of intensive care 
patients, reducing stress and fear in patients, communi-
cating with distressed patients, inspiring patients with 
confidence and hope, and summary and assessment). 
Local research teams will enumerate all clinical critical 
care staff at the start of the transition period, and then 
monthly thereafter to ensure new staff members are regis-
tered for the POPPI online training.
In addition, intervention group sites will ensure that 
POPPI materials are clearly displayed (eg, posters) and 
distributed (eg, pocket cards) throughout the unit.
Patients
Patients admitted to participating units will be routinely 
screened against the eligibility criteria:
Inclusion criteria
 ► Age 18 years or greater
 ► Greater than 48 hours in the critical care unit
 ► Receipt of level 3 critical care (for any period of time) 
during first 48 hours in the critical care unit
 ► Between +1 and −1 on the Richmond Agitation Seda-
tion Scale26
 ► Glasgow Coma Scale Score of 15
 ► English-speaking
 ► Ability to communicate orally
Exclusion criteria
 ► Pre-existing chronic cognitive impairment, such as 
dementia
 ► Pre-existing psychotic illness, such as schizophrenia
 ► Pre-existing chronic PTSD
 ► Receiving end-of-life care
 ► Previously recruited to POPPI
Patients who meet the eligibility criteria in the unit 
will be approached and provided with written and verbal 
information about POPPI by a member of the local 
research team. Potential participants will be given the 
opportunity to ask questions and time to discuss the trial 
with family or friends before making their decision. After 
the person seeking consent is satisfied that the infor-
mation has been understood and questions have been 
answered, they will invite the potential participant to sign 
the consent form. In providing informed consent, partic-
ipants are agreeing for the trial team to have access to 
their medical records for data collection and to receive a 
follow-up questionnaire at 6 months. In addition, partic-
ipants recruited at intervention group sites from month 
6 onwards (figure 1) will be offered the option to provide 
consent to receive an assessment with IPAT and subse-
quent stress support sessions (if applicable). Figure 3 
shows the timeline for a patient recruited at an interven-
tion group site from month 6 onwards.
On entry into the study, the participant’s general prac-
titioner (GP) will be informed, by letter, of their recruit-
ment into POPPI.
IPAT assessment
IPAT is a validated screening tool used to detect acute 
psychological stress and unusual experiences such as 
hallucinations in critically ill patients.23 Consenting, 
eligible patients at intervention group sites will be assessed 
using IPAT by a trained staff member as soon as possible, 
but within 48 hours of consent being provided. A patient 
is deemed highly stressed if they score seven or more on 
IPAT and should be referred, as soon as possible, to a 
POPPI nurse to receive the three stress support sessions. 
Patients who score less than 7 on IPAT will continue to 
receive usual care as determined by the treating clini-
cian(s). If the patient scores 5 or 6 on IPAT they will be 
reassessed daily, for a maximum of 3 days, until they either 
leave the critical care unit or the score drops below 5.
Stress support sessions
The main objectives of the stress support sessions are for 
nurses to develop a trusting relationship with patients, 
so patients can discuss concerns which they might feel 
embarrassed or worried about communicating, and to 
reduce emotional distress. There are three common 
components to each stress support session: starting the 
session; building rapport; and finishing the session. In 
addition, each session is structured as follows:
 ► Stress support session 1—‘helping patients under-
stand and cope with stress’
 – Normalise reactions
 – Encourage communication
 – Teach coping strategies
 ► Stress support session 2—‘managing frightening 
thoughts from critical care’
 – Stress reactions
 – Explain stressful thinking
 – Teach ‘check out my fear’ technique
 ► Stress support session 3—‘creating confidence and 
hope for a good recovery’
 – Summarise and review
 – Action plan
 – Future expectations
The three stress support sessions are to be delivered 
by the same POPPI nurse ideally within 1 week, with the 
first stress support session starting as soon as possible, but 
within 48 hours following IPAT assessment. Each session 
lasts approximately 30 min and ideally (at least) the first 
session is delivered in the critical care unit, but sessions 
can be delivered elsewhere in the hospital if the patient 
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moves. If a patient shows signs of distress or fatigue 
during the session, then the session can be stopped and 
a new visit can be arranged at a more appropriate time. 
The State-Trait Anxiety Inventory (STAI)27 will be used to 
assess a patient’s anxiety prior to session one (at baseline) 
and at the end of stress support session 3. If a patient is 
showing serious signs of distress at the end of their three 
sessions, their medical team will be informed.
Follow-up
All participants will be sent a follow-up questionnaire by 
the ICNARC CTU 6 months postrecruitment. The ques-
tionnaire contains the PTSD Symptom Scale – Self-Re-
port version (PSS-SR),28 the Hospital Anxiety and 
Depression Scale (HADS)29 the EuroQoL health ques-
tionnaire (EQ-5D-5L)30 and a health services and resource 
use questionnaire. Questionnaire packs include a self- 
addressed stamped envelope and a pen for ease of return. 
Non-responders will be telephoned 3 weeks later to check 
whether they have received the questionnaire and, if pref-
erable, they will be given the option to complete the ques-
tionnaire over the telephone. If completed questionnaires 
received at the ICNARC CTU indicate the presence of signs 
of serious stress, anxiety or depression, a referral letter from 
DW (lead clinical investigator) will be sent to the patient’s 
GP or the local PIs at the recruiting site.
outcomes
Primary outcomes
The primary outcome for the clinical evaluation is 
patient-reported PTSD symptom severity at 6 months, 
measured using PSS-SR,28 which conforms to the Diag-
nostic and Statistical Manual of Mental Disorders (fourth 
edition) diagnostic criteria for PTSD and which has been 
validated for use in critical care unit survivors.
The primary outcomes for the economic evaluation will 
be incremental costs, quality-adjusted life years (QALYs) 
and net monetary benefit at 6 months.
Secondary outcomes
Secondary outcomes are:
 ► days alive and free from sedation to day 30;
 ► duration of critical care unit stay;
 ► PSS-SR greater than 18 points at 6 months;31
 ► anxiety and depression at 6 months, measured using 
HADS;29
Figure 3 Patient timeline during the intervention period. IPAT, intensive care psychological assessment tool.
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 ► health-related quality of life (HRQoL) at 6 months, 
measured by EQ-5D-5L30 and
 ► estimated lifetime cost-effectiveness.
data collection
Table 1 shows the patient data collection schedule. The 
following data are collected by local research teams for all 
patients while in hospital:
 ► Patient details (identifiers, sociodemographics)
 ► Clinical/baseline data (date/time of critical care unit 
admission and consent, eligibility criteria, quality of 
life score, STAI27 score, prior delirium (assessed by 
the Confusion Assessment Method for the Intensive 
Care Unit (CAM-ICU),32 documented pre-existing 
anxiety or depression)
 ► Critical care unit stay data (duration of: delirium 
(assessed by CAM-ICU), sedatives, anxiolytics, anaes-
thetics, sleep medications, antipsychotics, analgesics, 
antidepressants, vasoactive agents and mechanical 
ventilation)
 ► Hospital discharge data (discharge status, date of 
discharge/death)
 ► POPPI intervention data (for patients recruited 
at intervention group sites during the interven-
tion period—IPAT Scores, delivery of stress support 
sessions, STAI Score after session 3)
Follow-up data (PSS-SR, HADS, EQ-5D-5L, health 
services and resource use) are collected via the patient 
follow-up questionnaire at 6 months postrecruitment. In 
addition, data will be linked to CMP and will include demo-
graphics, surgical status, acute severity of illness and dura-
tion of organ support, and duration of critical care unit stay. 
Support for the collection and use of patient-identifiable 
data has been approved for CMP by the Patient Informa-
tion Advisory Group (PIAG) under Section 251 of the NHS 
Act 2006—approval number: PIAG 2-10(f)/2005. Survival 
at 6 months will be ascertained through NHS Digital. All 
data are managed in accordance with ICNARC CTU stan-
dard operating procedures.
The process evaluation will consider both quantitative 
and qualitative data. Mixed-methods data will be collected 
for all three component parts of the intervention, to eluci-
date the degree to which the intervention was delivered as 
intended. Quantitative data will include the rate of online 
training uptake, treatment fidelity of the stress support 
sessions, and routinely collected screening and recruit-
ment data. At intervention group sites, qualitative data will 
be collected in the form of researcher observations, inter-
views with staff and structured field notes. An indepen-
dent researcher will observe and discuss the delivery of the 
intervention with the POPPI nurses and wider critical care 
unit staff, exploring clinician experiences including those 
relating to barriers and facilitators to the delivery of the 
intervention. The process evaluation will also incorporate 
visits to a purposively selected sample of control group sites. 
Qualitative data will be collected to understand wider trial 
processes including strategies to ensure/promote recruit-
ment, and any changes in unit practice from baseline.
Analysis
An overview of the planned analyses for the POPPI trial 
is provided below. The full statistical analysis plan will be 
submitted for publication ahead of database lock.
Clinical evaluation
The primary analysis for the clinical evaluation will deter-
mine if there is a significant difference in the mean PSS-SR 
at 6 months between patients recruited during the inter-
vention period at intervention sites compared with patients 
recruited at control sites using a generalised linear mixed 
model (GLMM) at the individual patient level (patients 
nested within sites and time periods) including a random 
effect of site and a fixed effect of period (baseline or inter-
vention), and adjusted for site-level factors included within 
the restricted randomisation algorithm.
For the primary outcome, the link function will be the 
identity link (ie, linear regression) and standard errors 
will be estimated using a jackknife variance estimate, 
which has been demonstrated in simulation studies to 
maintain the size of the test.33
A secondary analysis will adjust for prespecified base-
line factors associated with poor psychological outcome 
(eg, sedation) and ability to resource and deliver the 
intervention (eg, size of critical care unit, teaching status) 
at both patient and site levels. Results of GLMMs will be 
reported as differences in means, 95% CIs and P values.
Analyses of secondary outcomes will be conducted using 
GLMMs, with the identity link (ie, linear regression) for 
continuous secondary outcomes, reported as differences 
in means, and the logit link (ie, logistic regression) for 
binary secondary outcomes, reported as ORs.
The above analyses will evaluate the effectiveness of the 
intervention among all patients meeting the inclusion 
criteria and consenting to follow-up, based on the inten-
tion-to-treat principle. A further secondary analysis will 
use structural mean models with an instrumental variable 
of allocated treatment to estimate the efficacy (adher-
ence-adjusted causal effect) of the stress support sessions 
among those patients consenting to psychological assess-
ment and stress support sessions, assessed as being at 
high risk of psychological morbidity and receiving stress 
support sessions.34
Economic evaluation
A cost-effectiveness analysis (CEA) will be undertaken to 
assess the relative cost-effectiveness of the intervention 
versus usual care. Resource use and outcome data will 
be used to report cost-effectiveness at 6 months and to 
project the lifetime cost-effectiveness of each strategy.
The cost analysis will take a health and personal health 
services perspective. Resource use data will be combined 
with unit costs from the NHS Payment by Results database 
and from local Trust Finance Departments, to report the 
total costs per patient at 6 months for intervention versus 
usual care.35 36
HRQoL data from the EQ-5D-5L questionnaires at 
6 months will be combined with survival data using 
 o
n
 5 O
ctober 2018 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2017-020908 on 8 February 2018. Downloaded from 
8 Richards-Belle A, et al. BMJ Open 2018;8:e020908. doi:10.1136/bmjopen-2017-020908
Open Access 
Ta
b
le
 1
 
P
at
ie
nt
 d
at
a 
co
lle
ct
io
n 
sc
he
d
ul
e
B
as
el
in
e
(a
t 
p
o
in
t 
o
f 
re
cr
ui
tm
en
t)
E
nd
 o
f 
cr
it
ic
al
 
ca
re
 u
ni
t 
st
ay
In
te
rv
en
ti
o
n 
g
ro
up
 s
it
es
—
d
ur
in
g
 t
ra
ns
it
io
n 
an
d
 in
te
rv
en
ti
o
n 
p
er
io
d
s
S
ix
 m
o
nt
hs
 
p
o
st
re
cr
ui
tm
en
t
B
ef
o
re
 S
S
S
-I
D
ur
in
g
 s
es
si
o
ns
A
ft
er
 S
S
S
-I
II
C
ol
le
ct
ed
 in
ho
sp
ita
l
 
 P
at
ie
nt
 d
et
ai
ls
✓
 
 
 C
lin
ic
al
/b
as
el
in
e 
d
at
a
✓
 
 
 C
rit
ic
al
 c
ar
e 
un
it 
st
ay
✓
 
 
 IP
AT
 a
ss
es
sm
en
t
✓
 
 
 S
S
S
 d
el
iv
er
y
✓
 
 
 S
TA
I
✓
 
✓
 
C
ol
le
ct
ed
 v
ia
 fo
llo
w
-u
p
 q
ue
st
io
nn
ai
re
s 
se
nt
 t
o 
p
at
ie
nt
s
 
 P
S
S
-S
R
✓
 
 
 H
A
D
S
✓
 
 
 E
Q
-5
D
-5
L
✓
 
 
 H
ea
lth
 s
er
vi
ce
 a
nd
 r
es
ou
rc
e 
us
e
✓
 
E
Q
-5
D
-5
L,
 E
ur
oQ
oL
 H
ea
lth
 q
ue
st
io
nn
ai
re
; H
A
D
S
, H
os
p
ita
l A
nx
ie
ty
 a
nd
 D
ep
re
ss
io
n 
S
ca
le
; I
PA
T,
 In
te
ns
iv
e 
ca
re
 P
sy
ch
ol
og
ic
al
 A
ss
es
sm
en
t 
To
ol
; P
S
S
-S
R
, P
os
t-
tr
au
m
at
ic
 S
tr
es
s 
D
is
or
d
er
 
S
ym
p
to
m
 S
ca
le
 -
 S
el
f R
ep
or
t 
ve
rs
io
n;
 S
S
S
, s
tr
es
s 
su
p
p
or
t 
se
ss
io
n(
s)
; S
TA
I, 
S
ta
te
-T
ra
it 
A
nx
ie
ty
 In
ve
nt
or
y.
 o
n
 5 O
ctober 2018 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2017-020908 on 8 February 2018. Downloaded from 
 9Richards-Belle A, et al. BMJ Open 2018;8:e020908. doi:10.1136/bmjopen-2017-020908
Open Access
linear interpolation to report QALYs at 6 months. CEA 
will follow the intention-to-treat principle and report the 
mean (95% CI) incremental costs, QALYs and net mone-
tary benefit at 6 months.
CEA will use multilevel linear regression models that allow 
for clustering37 including a random effect of site and a fixed 
effect of period. The analysis will adjust for prespecified base-
line covariates at both patient level and site level.
Lifetime cost-effectiveness will be projected by encap-
sulating the relative effects of the alternative strategies 
on long-term survival and HRQoL, combining extrap-
olations from the patient survival data, with external 
evidence on long-term survival and HRQoL.38 39 The 
long-term survival of patients will be extrapolated from 
the cluster-RCT data by fitting alternative parametrical 
survival curves (eg, Weibull, exponential, lognormal, log 
logistic and Gompertz) to the observed survival data. The 
method of parametrical extrapolation of survival for the 
base case will be chosen on the basis of model fit and plau-
sibility when compared with age-gender matched general 
population survival.40 Survival will then be extrapolated 
according to the chosen parametrical function for the 
duration of years that parametrical curves predict excess 
mortality compared with the age-gender matched general 
population, after which we will assume that all-cause 
death rates were those of the age-gender matched general 
population. In the base case, quality of life calculated at 
6 months will be assumed to apply to each subsequent 
year of life, after allowing for decrements in quality of 
life according to advancing age. We will project lifetime 
costs by applying morbidity costs estimated at 6 months 
over the period of excess mortality. Predicted survival and 
HRQoL will be combined to report lifetime QALYs, and 
to project lifetime incremental costs, incremental QALYs 
and incremental net benefits for the alternative strategies 
of care. Sensitivity analyses will test whether the results are 
robust to methodological assumptions (eg, specification 
of the statistical model, extrapolation approach, alterna-
tive HRQoL assumptions and learning curve effects).
Process evaluation
The process evaluation data will be analysed using a 
combination of qualitative and quantitative methods to 
measure and understand the reason for any variation in 
the delivery of the intervention across sites. Interview data 
will be transcribed and analysed using a seven-stepped 
framework approach41 which includes coding the data, 
developing and applying an analytical framework, and 
producing data summaries. A sample of transcripts will 
be double-coded and reviewed by another independent 
member of the research team to ensure trustworthiness 
and confirmability. Data summaries will be interpreted 
and used to construct overall explanations of the data by 
two members of the research team.
Analysis of the process evaluation data will be conducted 
before the outcome evaluation to avoid any bias in the 
interpretation of the data, and to generate hypotheses 
that may be subsequently tested in statistical analyses of 
integrated process and outcome data. The process evalu-
ation data will be combined with the trial outcome data to 
uncover the relationship between the variation in inter-
vention delivery and trial outcomes.
Power calculation
Pretrial power calculation
The power calculation was completed using the approach 
of Hussey and Hughes (2007)33 to achieve 90% power to 
detect a reduction from 6 points to 3.1 points (P<0.05) 
in the mean PSS-SR at 6 months, and was based on the 
following assumptions:
 ► Mean (6) and SD (7.5) of the PSS-SR were taken from 
patients in the feasibility study
 ► Estimated intracluster correlation (ICC) of 0.138—
between-site coefficient of variation 0.5 corresponding 
to between-site SD of 3 (conservative estimate as no 
multicentre data available).42 Note: the inclusion of 
a baseline recruitment period means that the sample 
size calculation is less sensitive to the degree of 
clustering33
 ► Treatment effect of a reduction of 2.9 points on PSS-SR 
based on: reliable change index for the PSS-SR of 8.6 
points43 being observed in 40% of eligible patients in 
the intervention periods assessed as being at high risk 
of psychological morbidity using IPAT, with 16% of 
recruiting patients declining the intervention
 ► Harmonic mean of the number of patients completing 
follow-up (52 per site per annum—corresponding to 
22 in a 5-month period) based on data from CMP
With the design and the above assumptions, the esti-
mated total number of patients recruited (based on CMP 
data) for the RCT would be 1914 patients from the 24 
sites. It is anticipated that 438 will be assessed using IPAT, 
of which 175 (40%) will be assessed as being at high risk 
of psychological morbidity and receive the stress support 
sessions.
Final review of assumptions in pretrial power calculation
During recruitment, in consultation with the Trial 
Steering Committee (TSC) and Data Monitoring and 
Ethics Committee (DMEC), a review of assumptions 
underlying the pretrial power calculation was conducted 
once outcome data were available for patients recruited 
during the 5-month baseline period in both the interven-
tion group and control group sites. This review, under-
taken using data available on 9 August 2016, identified 
the following re-estimations of the assumptions:
 ► Mean (10.3) and SD (10.8) of PSS-SR
 ► ICC of 0.087 (95% CI 0 to 0.192) (with mean, SD and 
ICC estimated using all available data from a previous 
observational study, the feasibility study and the base-
line period of the cluster-RCT)
 ► Treatment effect of a reduction of 4.2 points on 
PSS-SR—estimated by retaining the same effect size as 
a multiple of the within-site SD
 ► Harmonic mean of the number of patients completing 
follow-up (30.7 per site per annum —corresponding 
 o
n
 5 O
ctober 2018 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2017-020908 on 8 February 2018. Downloaded from 
10 Richards-Belle A, et al. BMJ Open 2018;8:e020908. doi:10.1136/bmjopen-2017-020908
Open Access 
to 12.8 in a 5-month period) estimated using observed 
data from the baseline period
This review established that the planned design had an 
anticipated 78% power under the observed parameter 
estimates (allowing for uncertainty in the between-site 
variation, between 73% and 85% power).
Consequently, the decision was taken to extend recruit-
ment in all sites to the end of planned recruitment for the 
final group of eight sites (corresponding to an harmonic 
mean of 16.5 patients completing follow-up per site during 
the intervention period, allowing for the variation from 
5 months to 9 months duration across sites, figure 1). With 
this extension to recruitment, the planned design had an 
anticipated 85% power (allowing for uncertainty in the 
between-site variation, between 79% and 91% power). It 
was anticipated that, with this extension to recruitment, 
the estimated total number of patients recruited would be 
1378. Recruitment continued to be monitored to ensure 
1378 or more patients were recruited. A final decision to 
extend recruitment by an additional 2 months in all sites 
was taken to ensure this minimum number was achieved. 
A protocol amendment was implemented to reflect this 
review of assumptions and the extension to the recruitment 
period.
oversight
The Trial Management Group (TMG) is responsible for 
the management of POPPI and is led by KMR (chief inves-
tigator) and PRM (senior researcher). In addition, TMG 
comprises the trial investigators and relevant ICNARC Clin-
ical Trials Unit (CTU) staff, who meet regularly to discuss the 
progress of the trial. ICNARC is trial sponsor (contact details 
available on http://www. icnarc. org), and ICNARC CTU 
is responsible for day-to-day trial management, is the data 
custodian, and will conduct central and on-site monitoring 
of sites and data. POPPI is managed according to the prin-
ciples of the International Conference on Harmonisation 
Good Clinical Practice. ICNARC CTU will act to preserve 
patient confidentiality and will not disclose or reproduce 
any information by which patients could be identified. Any 
patient identifiable data leaving sites will be encrypted to 
ensure anonymity. All procedures for handling, processing, 
storing and destroying data are compliant with the Data 
Protection Act 1998.
TSC and DMEC have been convened as trial over-
sight committees. TSC is independently chaired by 
Professor Sallie Lamb and includes critical care clini-
cians, psychologists, patient and public involvement 
representatives, along with the chief investigator and 
lead clinical investigator. TSC monitors trial progress 
and at least 75% of members are independent. The 
independent DMEC is chaired by Professor Marion 
Campbell and also includes an experienced critical 
care clinician and an experienced statistician. DMEC 
is independent of both the trial team, sponsor and 
TSC, and operates under the DAMOCLES Charter,44 
reporting to TSC, making recommendations on the 
continuation, or not, of the trial.
trIAl stAtus
This paper presents the protocol (V.2.2, 6 March 2017) 
for the first, large, multicentre cluster-RCT evaluating a 
complex intervention commencing in the critical care unit 
and aimed at reducing longer-term psychological morbidity 
for critical care survivors in the UK. The full p rotocol 
(including amendments) is available on the NIHR website. 
45 The first participant was recruited in September 2015. At 
the time of first manuscript submission, data collection for 
the trial was ongoing and due to be complete in December 
2017. The trial results will be disseminated in 2018 through 
presentations at national and international conferences 
and publication in peer reviewed medical journals.
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